XML 19 R42.htm IDEA: XBRL DOCUMENT

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)

12 Months Ended

Mar. 28, 2020

Segment Reporting [Abstract]

Selected Information by Business Segment



(In thousands)	2020				2019				2018
Net revenues
Plasma	$	460,637			$	426,781			$	363,254
Blood Center	325,661				335,557				347,373
Hospital	194,604				190,821				178,116
Net revenues by business unit	980,902				953,159				888,743
Service ⁽¹⁾	19,830				19,906				20,574
Effect of exchange rates	(12,253		)		(5,486		)		(5,394		)
Net revenues	$	988,479			$	967,579			$	903,923
⁽¹⁾ Reflects revenue for service, maintenance and parts.



(In thousands)	2020				2019				2018
Segment operating income
Plasma	$	225,351			$	180,300			$	146,986
Blood Center	159,802				163,628				170,172
Hospital	80,669				76,338				67,258
Segment operating income	465,822				420,266				384,416
Corporate expenses ⁽¹⁾	(255,727		)		(263,603		)		(257,229		)
Effect of exchange rates	7,920				8,367				4,060
Impairment of assets and other related charges ⁽²⁾	(51,220		)		(21,170		)		(1,941		)
Deal amortization	(25,746		)		(24,803		)		(26,013		)
PCS2 accelerated depreciation and related costs	(24,530		)		(19,126		)		—
Restructuring and turnaround costs	(19,878		)		(13,660		)		(44,125		)
European Medical Device Regulation costs	(1,506		)		—				—
Other ⁽³⁾	133				(2,726		)		(3,011		)
Gain on sale of assets ⁽⁴⁾	8,083				—				—
Operating income	$	103,351			$	83,545			$	56,157
⁽¹⁾ Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions. ⁽²⁾ Includes a $1.9 million adjustment to fiscal 2020 Plasma revenue due to an accelerated charge incurred as a result of the divestiture of the Union, South Carolina liquid solutions operation. ⁽³⁾ Includes transaction costs and costs related to the resolution of customer damages associated with product recalls. ⁽⁴⁾ Reflects gain on the sale of the Company's Braintree corporate headquarters.



(In thousands)	2020				2019				2018
Depreciation and amortization
Plasma	$	38,429			$	38,074			$	47,985
Blood Center	8,513				9,623				11,439
Hospital	63,347				61,721				29,823
Total depreciation and amortization (excluding impairment charges)	$	110,289			$	109,418			$	89,247



(In thousands)	March 28, 2020				March 30, 2019				March 31, 2018
Long-lived assets⁽¹⁾
Plasma	$	141,903			$	192,628			$	186,007
Blood Center	93,758				127,272				122,898
Hospital	17,738				24,079				23,251
Total long-lived assets	$	253,399			$	343,979			$	332,156
⁽¹⁾ Long-lived assets are comprised of property, plant and equipment.

Selected information by principle operating regions is presented below:



(In thousands)	March 28, 2020				March 30, 2019				March 31, 2018
Long-lived assets⁽¹⁾
United States	$	186,488			$	269,849			$	236,603
Japan	2,037				1,726				1,511
Europe	10,143				11,200				13,696
Asia	29,175				30,930				36,431
Other	25,556				30,274				43,915
Total long-lived assets	$	253,399			$	343,979			$	332,156
⁽¹⁾ Long-lived assets are comprised of property, plant and equipment.



(In thousands)	2020				2019				2018
United States	$	646,204			$	606,845			$	548,731
Japan	72,218				69,908				67,319
Europe	153,347				164,504				164,226
Asia	109,295				118,700				115,127
Other	7,415				7,622				8,520
Net revenues	$	988,479			$	967,579			$	903,923

Schedule of Revenues by Product Line

et revenues by product line are as follows:



(In thousands)	2020				2019				2018
Plasma products and services	537,231				501,837				435,956
Blood Center products and services	252,829				269,203				284,902
Hospital products and services	198,419				196,539				183,065
Net revenues	$	988,479			$	967,579			$	903,923